Beta Bionics Inc (BBNX)

Finanzdaten der Beta Bionics Inc-Aktie (BBNX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.91%35.51	32.01	27.63	32.12	27.25
Cost Of Revenue	15.73%15.17	13.11	11.19	13.18	12.13
Gross Profit	7.56%20.33	18.90	16.44	18.94	15.12
	5.53%46.94	44.48	40.71	35.07	32.16
Research and Development	16.94%11.98	10.24	10.36	10.13	8.20
Operating Income/Loss	4.03%-26.61	-25.58	-24.27	-16.12	-17.04
Nonoperating Income/Loss	3.72%2.26	2.18	2.38	2.66	2.83
	4.06%-24.35	-23.40	-21.90	-13.47	-14.21
Attributable To Parent	4.06%-24.35	-23.40	-21.90	-13.47	-14.21
Basic Average Shares	4.48%46.54	44.55	44.44	-	43.63
Diluted Average Shares	4.48%46.54	44.55	44.44	-	43.63
Basic Earnings Per Share	1.89%-0.52	-0.53	-0.49	-	-0.33
Diluted Earnings Per Share	1.89%-0.52	-0.53	-0.49	-	-0.33